BSE Live
Jan 23, 16:01Prev. Close
1634.40
Open Price
1640.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:57Prev. Close
1634.20
Open Price
1640.00
Bid Price (Qty.)
1631.90 (3)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 92.76 | 46.38 | |
| Total Share Capital | 94.16 | 61.83 | |
| Reserves and Surplus | 1,011.28 | 797.73 | |
| Total Reserves and Surplus | 1,011.28 | 797.73 | |
| Total Shareholders Funds | 1,105.44 | 859.56 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 1,770.11 | 197.31 | |
| Deferred Tax Liabilities [Net] | 87.94 | 77.90 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 1,858.05 | 275.21 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 44.54 | 114.94 | |
| Trade Payables | 83.13 | 78.48 | |
| Other Current Liabilities | 53.88 | 35.09 | |
| Short Term Provisions | 84.45 | 73.37 | |
| Total Current Liabilities | 266.00 | 301.88 | |
| Total Capital And Liabilities | 3,229.50 | 1,436.66 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 398.18 | 326.22 | |
| Intangible Assets | 40.97 | 40.97 | |
| Capital Work-In-Progress | 47.94 | 26.07 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 487.09 | 393.26 | |
| Non-Current Investments | 985.24 | 558.93 | |
| Deferred Tax Assets [Net] | 2.64 | 3.84 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | |
| Total Non-Current Assets | 1,474.97 | 956.03 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 186.62 | 161.45 | |
| Trade Receivables | 234.97 | 128.37 | |
| Cash And Cash Equivalents | 890.03 | 75.75 | |
| Short Term Loans And Advances | 442.91 | 115.06 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 1,754.53 | 480.63 | |
| Total Assets | 3,229.50 | 1,436.66 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 39.77 | 26.38 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 81.68 | 72.65 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 26.33 | 19.59 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 66.27 | 29.25 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | 275.10 | 204.11 | |
| Other Earnings | 11.55 | 1.64 | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | 80.82 | 34.44 | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | 304.17 | 529.91 | |
| Non-Current Investments Unquoted Book Value | 950.63 | 383.55 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
07.01.2026
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend